Back to search

Article

<i>In Vivo</i> Assessment of the Safety of Standard Fractionation Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma: An R-IDEAL Stage 1/2a First-in-Humans/Feasibility Demonstration of New Technology Implementation

2021-01-06

Abstract excerpt

<h4>Introduction</h4> Prior in silico simulations of studies of Temporally Feathered Radiation Therapy (TFRT) have demonstrated potential reduction in normal tissue toxicity. This R-IDEAL Stage 1/2A study seeks to demonstrate the first-in-human implementation of TFRT in treating patients with head and neck squamous cell carcinoma (HNSCC). <h4>Materials and Methods</h4> Patients with HNSCC treated with definitive r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4cd51fbb-253c-505f-9b84-e09a3230db27
DOI
10.1101/2021.01.05.21249232
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In Vivo</i> Assessment of the Safety of Standard Fractionation Temporally Feathered Radiation Therapy (TFRT) for Head and Neck Squamous Cell Carcinoma: An R-IDEAL Stage 1/2a First-in-Humans/Feasibility Demonstration of New Technology ImplementationDOI 10.1101/2021.01.05.21249232
Select a neighboring publication to make it the new centre.